Kanser biyolojisi alan\u0131nda \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131 olarak kabul edilen yeni bir \u00e7al\u0131\u015fma, oral skuam\u00f6z h\u00fccreli karsinomun (OSCC) geli\u015fiminde erken d\u00f6nemdeki molek\u00fcler mekanizmalar\u0131 ortaya koyuyor. Boston \u00dcniversitesi\u2019nden Dr. Manish Bais ve Florida \u00dcniversitesi ekiplerinin ortak \u00e7al\u0131\u015fmas\u0131, epigenetik d\u00fczenleyici olarak g\u00f6rev yapan lizine \u00f6zg\u00fc demetilaz 1\u2019in (LSD1) OSCC\u2019nin ba\u015flat\u0131lmas\u0131nda ve ilerlemesinde kritik bir rol \u00fcstlendi\u011fini bilim d\u00fcnyas\u0131na sundu. \u00c7al\u0131\u015fma, LSD1 aktivitesinin preneoplastik lezyonlar\u0131 invaziv oral kanser evresine ta\u015f\u0131yan oncogenik ve imm\u00fcns\u00fcpresif sinyal yollar\u0131yla bire bir ba\u011flant\u0131l\u0131 oldu\u011funu g\u00f6stermekle kalmay\u0131p, bu s\u00fcre\u00e7te yeni hedef noktalar belirleyerek tedavi alan\u0131nda umut vadediyor.<\/p>\n
Epigenetik d\u00fczenlenme, histon proteinlerinin belirli amino asit kal\u0131nt\u0131lar\u0131nda ger\u00e7ekle\u015fen post-translasyonal modifikasyonlar \u00fczerinden kromatin yap\u0131s\u0131n\u0131 ve gen ekspresyonunu y\u00f6neterek h\u00fccresel kimlik ve homeostaz\u0131 sa\u011flar. LSD1 enzimi, histon H3\u2019\u00fcn 4. ve 9. lisin kal\u0131nt\u0131lar\u0131ndaki metil gruplar\u0131n\u0131 se\u00e7ici olarak \u00e7\u0131karan bir demetilazd\u0131r. Bu i\u015flevi sayesinde belirli genlerin a\u00e7\u0131lmas\u0131n\u0131 veya kapanmas\u0131n\u0131 sa\u011flar. Bahsi ge\u00e7en yeni ara\u015ft\u0131rmada, erken evre OSCC\u2019de LSD1 aktivitesinin anormal art\u0131\u015f\u0131, siklin-ba\u011f\u0131ml\u0131 kinaz 7 (CDK7) \u00fczerindeki fosforilasyon durumlar\u0131n\u0131 de\u011fi\u015ftirerek kanser h\u00fccrelerinin \u00e7o\u011falmas\u0131n\u0131 ve transkripsiyonel d\u00fczeni devam ettiriyor. CDK7\u2019nin bu i\u015flevi, kanser geli\u015fiminde ve ba\u011f\u0131\u015f\u0131kl\u0131k sisteminden ka\u00e7\u0131\u015fta kilit bir akt\u00f6r olan STAT3 yolunun s\u00fcrekli aktif kalmas\u0131na neden oluyor.<\/p>\n
Ara\u015ft\u0131rma ekipleri, genetik olarak LSD1\u2019in ortadan kald\u0131r\u0131ld\u0131\u011f\u0131 modeller ve spesifik LSD1 inhibit\u00f6r\u00fc SP2509\u2019un kullan\u0131ld\u0131\u011f\u0131 deneyler sayesinde OSCC\u2019nin preneoplastik ilerleyi\u015finin belirgin bi\u00e7imde engellendi\u011fini g\u00f6stermi\u015ftir. Bu m\u00fcdahaleler yaln\u0131zca h\u00fccre proliferasyonunun yava\u015flamas\u0131na yol a\u00e7makla kalmam\u0131\u015f, ayn\u0131 zamanda t\u00fcm\u00f6r mikro\u00e7evresinin ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 destekler bi\u00e7imde yeniden \u015fekillenmesini de sa\u011flam\u0131\u015ft\u0131r. En dikkat \u00e7ekeni ise, LSD1 inhibit\u00f6rlerinin CTLA4 ekspresyonunu azaltarak CD8+ sitotoksik T h\u00fccrelerinin i\u015flevini engelleyen immunsupresif bariyerleri kald\u0131rmas\u0131 olmu\u015f, bu durum t\u00fcm\u00f6r i\u00e7i ba\u011f\u0131\u015f\u0131kl\u0131k tepkilerinin g\u00fc\u00e7lenmesini beraberinde getirmi\u015ftir.<\/p>\n
\u00c7al\u0131\u015fman\u0131n en somut sonu\u00e7lar\u0131ndan biri, veteriner klinik \u00e7al\u0131\u015fmalar\u0131nda Seclidemstat adl\u0131 LSD1 inhibit\u00f6r\u00fcn\u00fcn hem g\u00fcvenli\u011fini hem de etkinli\u011fini kedilerdeki OSCC modellerinde kan\u0131tlamas\u0131d\u0131r. Seclidemstat, STAT3 fosforilasyonunu bask\u0131layarak t\u00fcm\u00f6r b\u00fcy\u00fcmesini engellemi\u015f ve ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin t\u00fcm\u00f6r b\u00f6lgesine daha yo\u011fun g\u00f6\u00e7 etmesini sa\u011flam\u0131\u015ft\u0131r. Bu t\u00fcr veteriner \u00f6n \u00e7al\u0131\u015fmalar\u0131, insan klinik denemeleri \u00f6ncesi \u00f6nemli k\u00f6pr\u00fcler kurarak hastal\u0131kla m\u00fccadelede LSD1 inhibit\u00f6rlerinin pratik potansiyelini ortaya koymu\u015ftur.<\/p>\n
Molek\u00fcler detaylara indi\u011fimizde, LSD1\u2019in CDK7 aktivitesini \u00f6zg\u00fcl fosforilasyon b\u00f6lgeleri arac\u0131l\u0131\u011f\u0131yla d\u00fczenledi\u011fi anla\u015f\u0131lmaktad\u0131r. CDK7, transkripsiyon fakt\u00f6r\u00fc TFIIH\u2019n\u0131n bir par\u00e7as\u0131 olarak RNA polimeraz II\u2019nin C-terminal domaininin fosforilasyonunda g\u00f6rev al\u0131r ve b\u00f6ylece global transkripsiyonel uzama s\u00fcre\u00e7lerini etkiler. LSD1\u2019in bu enzimi a\u015f\u0131r\u0131 aktive etmesi, STAT3 sinyal yolunu s\u00fcrekli a\u00e7\u0131k tutarak epitel h\u00fccre d\u00f6n\u00fc\u015f\u00fcm\u00fcne ve t\u00fcm\u00f6rleyici imm\u00fcns\u00fcpresyona yol a\u00e7ar. Bu LSD1-CDK7-STAT3 ekseni, OSCC\u2019nin preneoplastik evresinde ortaya \u00e7\u0131kan \u00f6nemli bir molek\u00fcler yolak olarak tan\u0131mlanm\u0131\u015ft\u0131r.<\/p>\n
Kanserlerde ba\u011f\u0131\u015f\u0131kl\u0131ktan ka\u00e7\u0131\u015f stratejileri her zaman hastal\u0131\u011f\u0131n ilerleyi\u015finde temel bir unsurdur. LSD1 inhibit\u00f6rlerinin CTLA4 proteinini bask\u0131layarak imm\u00fcns\u00fcpresyonu giderdi\u011finin g\u00f6sterilmesi, t\u00fcm\u00f6r-ba\u011f\u0131\u015f\u0131kl\u0131k etkile\u015fimlerinde yeni bir d\u00f6nemin ba\u015flang\u0131c\u0131n\u0131 m\u00fcjdelemektedir. CD8+ T h\u00fccrelerinin t\u00fcm\u00f6r b\u00f6lgelerine daha etkin \u015fekilde yerle\u015fmesi ve i\u015flev kazanmas\u0131, epigenetik reg\u00fclat\u00f6rlerin erken evre OSCC\u2019de ba\u011f\u0131\u015f\u0131kl\u0131k manzaras\u0131n\u0131 \u015fekillendirmede kritik roller oynad\u0131\u011f\u0131n\u0131 kan\u0131tlam\u0131\u015ft\u0131r. Bu kapsamda LSD1 inhibit\u00f6rlerinin mevcut imm\u00fcnoterapi y\u00f6ntemleriyle kombinasyonu, OSCC tedavisinde tedavi direncini a\u015fmada yeni stratejiler sunmaktad\u0131r.<\/p>\n
Geleneksel olarak OSCC daha \u00e7ok invazif evrelerde tan\u0131 al\u0131p tedaviye al\u0131n\u0131rken, bu \u00e7al\u0131\u015fma t\u00fcm\u00f6r geli\u015fiminin preneoplastik a\u015famalar\u0131nda m\u00fcdahale etmenin m\u00fcmk\u00fcn oldu\u011funa i\u015faret ediyor. Epigenetik d\u00fczenleyicilerin hedeflenmesiyle hastal\u0131k hen\u00fcz ba\u015flamadan ya da erken ba\u015flad\u0131\u011f\u0131nda durdurulmas\u0131, tedavide paradigmay\u0131 de\u011fi\u015ftirecek yenilikler sunuyor. Erken evre OSCC tedavisinde LSD1 inhibit\u00f6rleri kullan\u0131lmas\u0131, hastal\u0131k insidans\u0131n\u0131 ciddi \u015fekilde azaltabilir ve ileri evre tedavilerinde g\u00f6r\u00fclen y\u00fcksek morbiditeyi \u00f6nleyebilir.<\/p>\n
Bu ara\u015ft\u0131rma ayn\u0131 zamanda kanser epigeneti\u011fi alan\u0131nda \u00f6nemli bir ilerlemenin habercisi. Genetik mutasyonlar d\u0131\u015f\u0131ndaki epigenetik modifikasyonlar\u0131n t\u00fcm\u00f6r progresyonundaki rollerine dikkat \u00e7ekmekle birlikte, ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin yeniden harekete ge\u00e7irilmesini de i\u00e7eren \u00e7ok y\u00f6nl\u00fc tedavi yakla\u015f\u0131mlar\u0131n\u0131n \u00f6nemini peki\u015ftiriyor. LSD1 inhibit\u00f6rlerinin ba\u011f\u0131\u015f\u0131kl\u0131k kontrol noktas\u0131 engelleyicileriyle kombine edilmesi, t\u00fcm\u00f6rle konak\u00e7\u0131 aras\u0131ndaki karma\u015f\u0131k etkile\u015fimi bozarak kal\u0131c\u0131 t\u00fcm\u00f6r bask\u0131lamas\u0131 sa\u011flama potansiyeline sahip.<\/p>\n
Hem fare modellerinde hem de kedilerdeki OSCC deneylerinde elde edilen kuvvetli \u00f6n sonu\u00e7lar, insanlarda yap\u0131lacak klinik \u00e7al\u0131\u015fmalara haz\u0131rl\u0131k niteli\u011finde. G\u00fc\u00e7l\u00fc, se\u00e7ici LSD1 inhibit\u00f6rlerinin geli\u015ftirilmesi ve uygun farmakokinetik \u00f6zelliklere sahip ila\u00e7lar\u0131n ortaya \u00e7\u0131kar\u0131lmas\u0131 bu alandaki ilerlemenin anahtarlar\u0131 aras\u0131nda. Ayr\u0131ca, tedaviden en fazla fayday\u0131 g\u00f6rebilecek hastalar\u0131n belirlenmesi amac\u0131yla biyobelirte\u00e7lerin ke\u015ffi ve kullan\u0131m\u0131, klinik ba\u015far\u0131n\u0131n anahtar unsurlar\u0131 olacakt\u0131r.<\/p>\n
Dr. Manish Bais ve \u00e7al\u0131\u015fma arkada\u015flar\u0131, epigenetik makineyi hedeflemenin sadece h\u00fccre \u00e7o\u011falmas\u0131n\u0131 durdurmakla kalmay\u0131p, ayn\u0131 zamanda kanserin alt etti\u011fi ba\u011f\u0131\u015f\u0131kl\u0131k g\u00f6zetimini yeniden kurmay\u0131 da ama\u00e7lad\u0131\u011f\u0131n\u0131 vurgulad\u0131. T\u00fcm\u00f6r\u00fc durdurman\u0131n yan\u0131 s\u0131ra do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131k savunmas\u0131n\u0131 yeniden canland\u0131ran b\u00f6ylesi \u00e7ift y\u00f6nl\u00fc yakla\u015f\u0131mlar, erken oral kanser tedavisinde sofistike ve umut verici bir ilerleme anlam\u0131na geliyor.<\/p>\n
Sonu\u00e7 olarak, LSD1\u2019in OSCC preneoplazisine olan etkisinin CDK7 fosforilasyonu ve STAT3 sinyalizasyonu yoluyla sa\u011fland\u0131\u011f\u0131n\u0131n a\u00e7\u0131klanmas\u0131, oral kanserin molek\u00fcler mekanizmalar\u0131na dair devrim niteli\u011finde bilgiler sunmaktad\u0131r. SP2509 ve Seclidemstat gibi LSD1 inhibit\u00f6rlerinin erken neoplastik de\u011fi\u015fiklikleri tersine \u00e7evirmede ve anti-t\u00fcm\u00f6r imm\u00fcniteyi art\u0131rmada etkinli\u011fi, hassas onkolojide yeni bir \u00e7a\u011f\u0131n kap\u0131s\u0131n\u0131 aralamaktad\u0131r. Epigenetik kontrol noktalar\u0131n\u0131 mod\u00fcle edip ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 etkinle\u015ftiren bu \u00e7oklu strateji, OSCC\u2019nin \u00f6nlenmesi ve tedavisinde yeni umutlar yarat\u0131yor.<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: Makale Ba\u015fl\u0131\u011f\u0131<\/strong>: Haberin Yay\u0131n Tarihi<\/strong>: Web References<\/strong>: Doi Referans<\/strong>: Resim Credits<\/strong>: Anahtar Kelimeler<\/strong>: Kanser biyolojisi alan\u0131nda \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131 olarak kabul edilen yeni bir \u00e7al\u0131\u015fma, oral skuam\u00f6z h\u00fccreli karsinomun (OSCC) geli\u015fiminde erken d\u00f6nemdeki molek\u00fcler mekanizmalar\u0131 ortaya koyuyor. Boston \u00dcniversitesi\u2019nden Dr. Manish Bais ve Florida \u00dcniversitesi ekiplerinin ortak \u00e7al\u0131\u015fmas\u0131, epigenetik d\u00fczenleyici olarak g\u00f6rev yapan lizine \u00f6zg\u00fc demetilaz 1\u2019in (LSD1) OSCC\u2019nin ba\u015flat\u0131lmas\u0131nda ve ilerlemesinde kritik bir rol \u00fcstlendi\u011fini bilim…<\/p>\n","protected":false},"author":1,"featured_media":5042,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","rank_math_title":"","rank_math_description":"","rank_math_focus_keyword":"","_wpan_schema_json_ld":"","_wpan_ai_seo_metadata":"","_wpan_ai_seo_status":"","_wpan_ai_seo_policy":"","_wpan_ai_seo_faq_block":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[6011,6012,6014,6013,6015],"tmauthors":[],"class_list":{"0":"post-5041","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-agiz-kanseri-epigenetik-tedavileri","9":"tag-lizine-ozgu-demetilaz-1-lsd1-inhibitorleri-oral-kanser","10":"tag-lsd1-inhibitorlerinin-bagisiklik-sistemi-uzerindeki-etkileri","11":"tag-oral-skuamoz-hucreli-karsinom-molekuler-mekanizmalari","12":"tag-seclidemstat-veteriner-klinik-calismalari-agiz-kanseri"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/05\/Agiz-Kanserinde-Epigenetik-Ilerleme-ve-Tedaviler-1746644420.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=5041"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5041\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/5042"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=5041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=5041"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=5041"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=5041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nOral skuam\u00f6z h\u00fccreli karsinomun preneoplastik evresinde yer alan epigenetik mekanizmalar ve LSD1\u2019in rol\u00fc<\/p>\n
\nLysine-specific demethylase 1 controls key OSCC preneoplasia inducer STAT3 through CDK7 phosphorylation during oncogenic progression and immunosuppression<\/p>\n
\n17 Nisan 2025<\/p>\n
\nhttp:\/\/dx.doi.org\/10.1038\/s41368-025-00363-x<\/p>\n
\n10.1038\/s41368-025-00363-x<\/p>\n
\ninternational journal of oral science<\/p>\n
\nOral kanser, epigenetik, LSD1, CDK7 fosforilasyonu, STAT3 sinyal yolu, OSCC preneoplazi, imm\u00fcns\u00fcpresyon, CTLA4, imm\u00fcnoterapi, SP2509, Seclidemstat, epigenetik tedaviler<\/p>\n","protected":false},"excerpt":{"rendered":"